KCNN4 and Stroke: As applied here to post-stroke neuroinflammation, the findings suggest that administration of the KCa3.1 inhibitor TRAM-34 starting 12 h after the ischemic insult and continued for 4 weeks reduces the amount of SNL and hastens recovery from sensorimotor deficit without a marked effect on MA, as assessed here using in vivo [11C]-PK11195 PET at day 14 and IB4 immunofluorescence at day 28, which may not tell the whole story regarding post-stroke neuroinflammation.